Our current study demonstrates that in pancreatic cancer, CTHRC1+ CAFs primarily rely on the LIF/STAT3 signaling pathway to promote pancreatic cancer cell growth and metastasis. Here, CTHRC1 is linked to pancreatic neoplasm.